News

Tandem Diabetes and Eli Lilly Collaborate on Insulin Pump Tech

Tandem Diabetes and Eli Lilly Collaborate on Insulin Pump Tech

Tandem Diabetes Care Partners with Eli Lilly for New Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), known for its innovation in insulin delivery systems, recently announced an exciting development. Their t:slim X2 insulin pump is now approved for use with Eli Lilly and Company’s Lyumjev ultra-rapid acting insulin in the United States. This marks a significant advancement in the tools available for managing diabetes.

Enhancing Diabetes Management with Smart Technology

Jordan Pinsker, MD, Chief Medical Officer at Tandem, highlighted this progression, stating, "This latest milestone reinforces our commitment to facilitating choice and access for people who rely on insulin therapy." This enhancement allows individuals aged two and above with type 1 diabetes, as well as adults with type 2 diabetes, to use Lyumjev in conjunction with the t:slim X2 pump. The flexibility offered here is a vital improvement for those managing diabetes.

Groundbreaking Study Results Support the Clearance

The approval for use of Lyumjev with the t:slim X2 was based on compelling data obtained from a 13-week multicenter study involving 179 participants. This research demonstrated high satisfaction levels and notable quality of life improvements among users. Although Lyumjev received general approval for use in insulin pumps in 2021, individual pump manufacturers had to validate compatibility through thorough testing.

Collaboration Between Tandem and Eli Lilly

Tandem and Lilly have diligently worked together to support this clinical trial, which corroborated the benefits of utilizing Lyumjev alongside Control-IQ+ technology. Furthermore, the companies are focused on securing compatibility for the Tandem Mobi pump with Lyumjev, further expanding options for patients.

Access and Support Through Lilly’s Insulin Value Program

Lyumjev is accessible to a large number of patients through the Lilly Insulin Value Program, which allows individuals with commercial insurance, as well as those without coverage, to fill a monthly prescription for just $35. This affordability initiative exemplifies a commitment to making necessary treatments accessible.

Broader Applicability of the t:slim X2 Pump

The t:slim X2 insulin pump has also been approved for use with other insulin types, including Humalog and Novolog, broadening the spectrum of choices available to users. This approval significantly enhances the versatility of the pump and its ability to cater to various patient needs.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care is committed to revolutionizing the management of diabetes through its cutting-edge insulin delivery systems. Their offerings include advanced technologies, such as the Tandem Mobi system and the t:slim X2 insulin pump, both of which incorporate the state-of-the-art Control-IQ+ technology. Based out of San Diego, the company focuses on reducing the strain of diabetes management for patients, healthcare providers, and families.

Connect With Tandem Diabetes Care

To stay updated about Tandem Diabetes Care, you can follow them on TikTok, and their various social media platforms, including Facebook, Instagram, LinkedIn, and X.

Frequently Asked Questions

What is the significance of the t:slim X2 insulin pump?

The t:slim X2 insulin pump is significant because it offers advanced features that help individuals manage their diabetes more effectively, including compatibility with innovative insulins like Lyumjev.

How does Control-IQ+ technology benefit users?

Control-IQ+ technology automatically adjusts insulin delivery based on glucose readings, helping to stabilize blood sugar levels and reduce the burden of diabetes management.

Who can use the t:slim X2 pump with Lyumjev?

Individuals aged two and older with type 1 diabetes, as well as adults with type 2 diabetes, can use the t:slim X2 pump with Lyumjev for insulin delivery.

How does the Lilly Insulin Value Program work?

The Lilly Insulin Value Program allows eligible individuals with or without insurance to obtain a monthly prescription of Lyumjev for only $35, making it more accessible.

What other insulins are compatible with the t:slim X2 pump?

In addition to Lyumjev, the t:slim X2 insulin pump is also approved for use with Humalog and Novolog insulin types, offering users more treatment options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 2

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading
Sony Expands Versatile Wireless Headphone Lineup: 2026

Updated Category News Views 3

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

Continue Reading
DNOW Faces Class Action: Proxy Missteps Under Fire

Updated Category News Views 1

DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
Chef André Chiang Reimagines A Joy's Autumn Menu

Updated Category News Views 3

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 1

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
Hoymiles' V2X Charger Revamps Home Energy Control

Updated Category News Views 5

Revolutionizing Home Energy with Hoymiles Here's a twist in the world of home energy that'll make any enthusiast pause—Hoymiles has launched their V2X DC Charger. This little number isn’t just a step up; it’s a giant leap toward integrating electric vehicles (EVs) into your home's energy system like never before. Nestled in Hangzhou, they've rolled this out as a...

Continue Reading
Potensic's ATOM 3 Invites Drone Creators to 'See Beyond'

Updated Category News Views 6

Innovative Features of Potensic's New Drone Potensic decided to shake things up a bit this year at IFA Berlin, showcasing their new creation: the ATOM 3 drone. Under the theme "SEE BEYOND," Potensic’s message to creators was clear—there’s more to explore in the world of visual storytelling than meets the eye. This drone isn't just another gadget; it's an invitation...

Continue Reading
Regan Hutsell Shines as 99th Miss America Winner

Updated Category News Views 0

There's a buzz in the air that's hard to ignore—Regan Hutsell from Texas secured the legendary Miss America crown. This event isn't just another chapter in the pageant's nearly century-old saga, but it's a spotlight moment that nods to Miss America's long-enduring cultural resonance. Now, you might be wondering: With all eyes on this Texan, what ripples could she send...

Continue Reading

Top 5 Most Recently Viewed Articles

ICON PLC Faces Class Action Lawsuit Amid Significant Losses

Updated Category News Views 287

ICON PLC Faces Class Action Lawsuit Amid Significant Losses The law firm of Robbins Geller Rudman & Dowd LLP has officially announced that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares have the opportunity to lead a class action lawsuit. This action is for investors who experienced significant financial losses between July 27, 2023, and October 23, 2024. The...

Continue Reading
Essex Property Trust EVP's Significant Stock Transaction Insights

Updated Category News Views 63

Recent Executive Stock Transactions In a significant move, Anne Morrison, serving as the Executive Vice President, Chief Administrative Officer, and General Counsel at Essex Property Trust, Inc. (NYSE: ESS), sold shares worth over $800,000. Specifically, she sold 2,571 shares at an average price of $314.79, totaling about $809,325. Investors closely watch insider trading...

Continue Reading
TDb Split Corp. Announces Key Financial Updates for Investors

Updated Category News Views 132

TDb Split Corp. Financial Overview TDb Split Corp. has recently published its annual financial statements for the fiscal year concluding on November 30, 2024. These documents detail the company's performance and are accessible for stakeholders to review. Annual Financial Performance Highlights The management report offers insights into the company's fund performance,...

Continue Reading
Baltic Horizon Fund Sees Positive NAV Growth in May 2025

Updated Category News Views 127

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Continue Reading
Fractyl Health's Insights on Q2 2025 Financial Performance

Updated Category News Views 135

Fractyl Health to Report Second Quarter 2025 Financial Results Fractyl Health, Inc. (Nasdaq: GUTS), a leader in metabolic therapeutics, is set to release its financial results for the second quarter of 2025. The report will be available on August 12, 2025, at 4:30 p.m. ET. This pivotal moment is crucial for stakeholders as the company shares insights into its financial...

Continue Reading